ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34,303 | +121.6% | 21,574 | 0.0% | 0.00% | – |
| Q1 2023 | $15,477 | -88.2% | 21,574 | +61.0% | 0.00% | -100.0% |
| Q1 2020 | $131,000 | -88.4% | 13,396 | -86.4% | 0.00% | -87.5% |
| Q4 2019 | $1,133,000 | +180.4% | 98,373 | +32.7% | 0.01% | +166.7% |
| Q3 2019 | $404,000 | +45.3% | 74,127 | +216.9% | 0.00% | 0.0% |
| Q2 2019 | $278,000 | +13800.0% | 23,391 | +3642.6% | 0.00% | – |
| Q4 2018 | $2,000 | -98.1% | 625 | -96.5% | 0.00% | -100.0% |
| Q1 2018 | $104,000 | +116.7% | 18,008 | +30.7% | 0.00% | – |
| Q4 2017 | $48,000 | +128.6% | 13,776 | +134.4% | 0.00% | – |
| Q3 2017 | $21,000 | +23.5% | 5,876 | -14.8% | 0.00% | – |
| Q2 2017 | $17,000 | -10.5% | 6,895 | 0.0% | 0.00% | – |
| Q1 2017 | $19,000 | +26.7% | 6,895 | +30.1% | 0.00% | – |
| Q4 2016 | $15,000 | +66.7% | 5,298 | +141.0% | 0.00% | – |
| Q3 2016 | $9,000 | -79.5% | 2,198 | -84.3% | 0.00% | -100.0% |
| Q2 2016 | $44,000 | – | 13,991 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 5,068,233 | $17,739,000 | 5.88% |
| Sonic Fund II, L.P. | 6,552,068 | $22,932,000 | 1.69% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $1,680,000 | 0.88% |
| Avoro Capital Advisors LLC | 6,950,000 | $24,325,000 | 0.42% |
| RTW INVESTMENTS, LP | 7,357,917 | $25,753,000 | 0.39% |
| K2 PRINCIPAL FUND, L.P. | 898,307 | $3,144,000 | 0.26% |
| Artal Group S.A. | 3,000,000 | $10,500,000 | 0.21% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,827,000 | $9,895,000 | 0.18% |
| WS MANAGEMENT LLLP | 307,442 | $1,076,000 | 0.11% |
| ALGERT GLOBAL LLC | 82,145 | $288,000 | 0.10% |